Background: Single-cell multiplex imaging data have provided new insights into disease subtypes and prognoses recently. However, quantitative models that explicitly capture single-cell resolution cell-cell interaction features to predict patient survival at a population scale are currently missing.
Methods: We quantified hundreds of single-cell resolution cell-cell interaction features through neighborhood calculation, in addition to cellular phenotypes. We applied these features to a neural-network-based Cox-nnet survival model to identify survival-associated features. We used non-negative matrix factorization (NMF) to identify patient survival subtypes. We identified atypical subpopulations of triple-negative breast cancer (TNBC) patients with moderate prognosis and Luminal A patients with poor prognosis and validated these subpopulations by label transferring using the UNION-COM method.
Results: The neural-network-based Cox-nnet survival model using all cellular phenotype and cell-cell interaction features is highly predictive of patient survival in the test data (Concordance Index > 0.8). We identify seven survival subtypes using the top survival features, presenting distinct profiles of epithelial, immune, and fibroblast cells and their interactions. We reveal atypical subpopulations of TNBC patients with moderate prognosis (marked by GATA3 over-expression) and Luminal A patients with poor prognosis (marked by KRT6 and ACTA2 over-expression and CDH1 under-expression). These atypical subpopulations are validated in TCGA-BRCA and METABRIC datasets.
Conclusions: This work provides an approach to bridge single-cell level information toward population-level survival prediction.
It may be possible to separate patients with cancer into different groups or subtypes based on the features of their tumor, such as the interactions between different types of cells in the tumor. In this study, we develop a computer-based model to calculate the interactions between cells in breast cancer images. We use these interactions to identify seven subtypes of patients with breast cancer with differences in their survival. We identify some subpopulations of patients with atypical survival outcomes. This work may ultimately help clinicians and researchers to identify patients with breast cancer at increased risk of poorer outcomes and to tailor their treatments accordingly.
© 2023. The Author(s).